Vinpocetine Market

Starting at US$ 5000

Buy Now
Companies
Industry Size (2023)
USD 365.9 Mn
Forecast (2033)
USD 546.9 Mn
CAGR (2023 to 2033)
4.1%

Vinpocetine Market Outlook 2023 to 2033

The global Vinpocetine market is expected to reach a market valuation of USD 365.9 Million by the year 2023, accelerating with a CAGR of 4.1% by 2023 to 2033. Vinpocetine sales are likely to account for a part of the demand in the global nutraceuticals market, valued at USD 546.9 Million in 2033.

Global study on nutraceuticals market explains that the increasing awareness of dietary supplements and Probiotics supplements, functional food and functional beverages in Covid era in order boost immunity and have healthy body has tremendously shifted market, increasing the sales of nutraceuticals.

In recent years, consumer behaviour towards health and wellness are consistently changing. As new trends emerge and exposure to information regarding various ailments and illnesses is rapidly increasing, companies operating in nutraceutical industry, are looking beyond their immediate competitors and product categories. The market for nutraceutical targeting brain health and cognition in particular has been garnering significant interest from a range of demographic groups.

Vinpocetine Market Size (2023E) USD 365.9 Million
Vinpocetine Market Projected Size (2033F) USD 546.9 Million
Value CAGR (2023-2033) 4.1%

Future Market Insights projects the market to remain lucrative, exhibiting growth at 4.1% CAGR between 2023 and 2033 in comparison to the CAGR of 6.0% posted between 2019 and 2022.

With more emphasis being placed on mental well-being, vinpocetine – a compound derived from the periwinkle plant – has been witnessing increasing demand for use as a supplement to improve biological aspects of memory and prevent cognitive impairment.

How Do the Vinpocetine Market's Historic and Future Outlook Compare?

Vinpocetine sales grew at a CAGR of 6.0% between 2018 and 2022.

As consumers are becoming increasingly aware of connection with balanced diet and mental health, demand for dietary supplements is on the rise. This, in turn, is projected to influence the growth of vinpocetine market. The cheese industry is growing at a very high rate. The demand of cheese all around the world has seen the many small- and large- scale industries arising. And so is the demand for Vinpocetine. The starter culture with all the specifics for that type of cheese is in demand in the market.

The vinpocetine market is further expected to benefit from growing consumer preference for multi-nutritional supplements to enhance their health status. With cognition being one of the most important public health concerns, a number of dietary supplements containing vinpocetine are being introduced to offer diverse cognitive benefits. However, it is pertinent to note that, no clinical research suggests that vinpocetine protects against slow aging of brain or dementia, while it failed to improve cognition in Alzheimer’s patients.

Recent FDA Action on Dietary Supplements Containing Vinpocetine to Impede Market Growth

The demand for various dietary supplements such as calcium supplements and fiber supplements continues to move on an upward swing. However, the use of vinpocetine in dietary supplements, especially in the USA, has come under intense scrutiny, on the account lack of clinical evidence to prove its benefits, undefined dosage parameters, and risks to human health. Vinpocetine has been widely sold in the country as a dietary supplement for about two decades.

Increasing claims from companies marketing dietary supplements containing vinpocetine as an active ingredient that the product helps improve athletic performance, boost memory loss, and in weight management has led to the rapid development of global vinpocetine market.

Country Wise Insights

Regions North America
Countries United States
CAGR in % 5.9%
Market Value Share in % (2023) 35%
Regions Europe
Countries United Kingdom
CAGR in % 4.9%
Market Value Share in % (2023) 15.3%
Regions Asia Pacific
Countries China, India, Japan
CAGR in % 5.6%, 4.9%, 4.4%
Market Value Share in % (2023) 17.9%, 9.7%, 8.8%

The Rise in Vinpocetine in Indian Market

The availability and use of Vinpocetine in the Indian market has increased significantly. Vinpocetine has been widely sold in the country as a dietary supplement for about two decades. It is considered a pharmaceutical available by prescription to treat cognitive impairment. Furthermore, as consumers become more aware of the benefits of these cultures, their appeal in the Indian market has increased.

What is the outlook of the Vinpocetine market in the USA?

The Vinpocetine market in the USA is expected to grow at a CAGR of 5.9 % during the forecasted period due to rising demand for natural and nutritious products. Cheese manufacturers are increasingly using Vinpocetine to improve the flavour and

The role of vinpocetine in neuroprotection and reducing neural inflammation is supported by several studies including a prospective analytical study conducted in the University of Benin Teaching Hospital, Nigeria. However, amount of scientific evidence on the efficacy of vinpocetine against cognitive decline is relatively less as compared to other drugs tested for this purpose. Generally, the outlook for the Vinpocetine market in the United States is positive, as consumers emphasise natural food items and there is a growing trend towards artisanal cheese production.

United Kingdom May Experience a Rising Trend during the Anticipated Period

According to FMI, Companies in the nutraceutical sector are expanding their search outside their direct rivals and product categories as new trends arise and exposure to knowledge about various conditions and illnesses rises quickly. Many demographic groups have shown a strong interest in the market for nutraceuticals that specifically target brain health and cognition.

Furthermore, the health benefits of using Vinpocetine, such as the promotion of healthy gut bacteria and immune systems, have contributed to the market's rise in the United Kingdom.

Category Wise Insights

Adjacent Markets Overview

Nutraceuticals Market:

Attributes Nutraceuticals Market
CAGR (2023 to 2033) 8.3%
Growth Factor Consumers’ drive towards maintaining healthy immune systems in the post-COVID era is predicted to propel nutraceuticals demand.
Opportunity Collaborations between players in the nutraceuticals market and prominent retail chains are set to increase brand awareness and generate significant demand.
Key Trends Collaborations between players in the nutraceuticals market and prominent retail chains are set to increase brand awareness and generate significant demand.

Nutraceuticals Excipients Market:

Attributes Nutraceuticals Excipients Market
CAGR (2023 to 2033) 10.4%
Growth Factor Over the years, rising prevalence of various diseases has prompted people to increase their nutritional intake and adopt healthy lifestyles. This in turn has brought markets such as nutraceuticals market and nutraceutical excipients market into the spotlight.
Opportunity Both manufacturers and regulators are paying much more attention to research and development these days. Numerous excipient technologies are no longer merely regarded as inactive components.
Key Trends Usage of novel excipients as potential solutions to the formulation of numerous exciting drug candidates that have previously been rejected due to their subpar physicochemical and/or pharmacokinetic properties will boost nutraceutical excipient sales.

Nutraceutical Gummies Market:

Attributes Nutraceutical Gummies Market
CAGR (2023 to 2033) 29%
Growth Factor Compared to traditional supplements, nutraceutical gummies have several advantages to offer. For starters, they are known for their high antioxidant content. Antioxidants can reduce the ill effects of a phenomenon known as oxidative stress.
Opportunity Increasing organic eating and veganism trends to contribute towards impressive market acceleration.
Key Trends Health benefits and practical advantages over conventional supplements to spur nutraceutical gummies demand.

Which Sales Channel is Contributing the Most Towards Nutraceuticals Sales?

Vinpocetine Nutraceuticals sales are greatly impacted by B2C sales or indirect sales through Health & Beauty Stores, Pharmacies/Drugstores, modern Trade Channel. Online retail channels are skyrocketing due in Covid Era.

Competitive Landscape

As dietary supplements continue to play an active part of the diet regimen in modern lifestyle, the demand for vinpocetine is expected to grow in near future. Although vinpocetine is not approved in the United States as a pharmaceutical, it is widely available as a supplement with reports stating the benefits for dementia patients. In addition, after over two decades of extensive use across Europe and Asia, side effects are rarely reported among consumers taking supplements containing vinpocetine, which is likely to influence in its demand. Despite recent claims regarding the adverse effects of vinpocetine, it remains widely available as a dietary supplement – often marketed as nootropics that are taken to improve cognitive function.

As the FDA leaves in doubt the future regulatory status of vinpocetine, manufacturers are focusing on demonstrating quality and efficacy of their products through notable scientific research.

Scope of the Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis USD Million for Value
Key Regions Covered North America, Latin America, Europe, East Asia, South Asia, and the Middle East & Africa
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Segments Covered Sales, Region
Key Companies Profiled
  • General Mills Inc.
  • The Nature’s Bounty Co. (NBTY)
  • Amway Enterprises
  • Herbalife International, Inc.
  • Royal DSM NV
  • Pepsi Co.
  • Yakult Honsha Co., Ltd.
  • Groupe Danone
  • Bayer AG
  • BASF SE
  • Abbott Laboratories
  • Chobani LLC
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers Restraints Opportunity Trends Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Vinpocetine Market by Category

By Distribution Channel:

  • Direct
  • Indirect
    • Health & Beauty Store
    • Pharmacies/Drugstores
    • Modern Trade Channel
    • Online Retailing

By Region:

  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • East Asia
  • South Asia
  • Oceania

Frequently Asked Questions

At what rate will the Vinpocetine Market grow?

Throughout the forecast period, the Vinpocetine Market is expected to grow at a CAGR of 4.1%

What is the expected value of the Vinpocetine Market by 2032?

By 2032, the Vinpocetine Market is expected to be worth USD 546.9 Million.

What are the key factors driving the Vinpocetine Market?

Consumers’ drive towards maintaining healthy immune systems in the post-COVID era is predicted to propel nutraceuticals demand.

Which region(s) adds to the highest Vinpocetine Market Valuation?

North America, at first and Europe at second are the most important consumers and have the largest market share.

Who are the key players in the Vinpocetine Market?

Some of the key players in the Vinpocetine Market include Fromgez, Inc., Dairy Connection, Inc., Chr. Hansen A/S, DSM Nutritional Products Ltd., Proxis Développement, E. I. du Pont de Nemours and Company, Lallemand Inc. They are thus concentrated on strategic endeavors to obtain significant market shares.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Vinpocetine Market